Literature DB >> 10985306

Rapid activation of lymph nodes and mononuclear cell HIV expression upon interrupting highly active antiretroviral therapy in patients after prolonged viral suppression.

J M Orenstein1, N Bhat, C Yoder, C Fox, M A Polis, J A Metcalf, J A Kovacs, J Falloon, R E Walker, H Masur, H C Lane, R T Davey.   

Abstract

OBJECTIVE: To compare the architecture and HIV-1 RNA and Gag p24 protein expression in lymph nodes (LN) excised from individuals during chronic highly active antiretroviral therapy (HAART) with LN removed from the same patient after plasma virus rebound following the interruption of HAART.
MATERIALS AND METHODS: Six HIV-1-infected patients on HAART, with CD4 cell counts greater than 350 cells/microl, and plasma HIV-1 RNA less than 50 copies/ml, underwent inguinal LN excision upon discontinuation of HAART, and again after rebound of plasma virus. Lymph nodes were evaluated by immunohistochemical staining for Gag p24 antigen and Ki67, in-situ hybridization for HIV-1 RNA and H3-histone, and transmission electron microscopy (TEM).
RESULTS: LN at baseline were quiescent to mildly hyperplastic and generally contained more primary than secondary follicles. Only one LN had detectable follicular dendritic cell (FDC)-associated p24 antigen, none had HIV RNA. Few mononuclear cells (MNC) expressed RNA or p24 antigen. Plasma virus at the second biopsy ranged from 329 to 3.2 x 10(6) copies/ml. CD4 cell count decline ranged from 5 to 51% during drug hiatus, and was greatest in patients with highest viral rebound. Four of six of the second LN were more hyperplastic than the initial LN, two showed paracortical hyperplasia. MNC expression of HIV RNA in the second LN paralleled the level of plasma viremia. Increased Ki67 and H3-histone signal occurred in the second LN.
CONCLUSION: Quiescent LN from individuals on HAART rapidly become hyperplastic and activated within 1-2 months after treatment interruption. As in acute HIV infection, virus expression by LN MNC parallels the rebound in plasma viremia and fall in CD4 cell count.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10985306     DOI: 10.1097/00002030-200008180-00004

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  7 in total

1.  Plasma levels of soluble CD27: a simple marker to monitor immune activation during potent antiretroviral therapy in HIV-1-infected subjects.

Authors:  A De Milito; S Aleman; R Marenzi; A Sonnerborg; D Fuchs; M Zazzi; F Chiodi; Fuchs D
Journal:  Clin Exp Immunol       Date:  2002-03       Impact factor: 4.330

2.  Evaluation of the pathogenesis of decreasing CD4(+) T cell counts in human immunodeficiency virus type 1-infected patients receiving successfully suppressive antiretroviral therapy.

Authors:  Elizabeth Nies-Kraske; Timothy W Schacker; David Condoluci; Jan Orenstein; Jason Brenchley; Cecil Fox; Marybeth Daucher; Robin Dewar; Elizabeth Urban; Brenna Hill; Javier Guenaga; Shelley Hoover; Frank Maldarelli; Claire W Hallahan; Judith Horn; Shyamasundaran Kottilil; Tae-Wook Chun; Marlene Folino; Sara Palmer; Ann Wiegand; M Angeline O'Shea; Julia A Metcalf; Daniel C Douek; John Coffin; Ashley Haase; Anthony S Fauci; Mark Dybul
Journal:  J Infect Dis       Date:  2009-06-01       Impact factor: 5.226

Review 3.  Is the central nervous system a reservoir of HIV-1?

Authors:  Lachlan R Gray; Michael Roche; Jacqueline K Flynn; Steve L Wesselingh; Paul R Gorry; Melissa J Churchill
Journal:  Curr Opin HIV AIDS       Date:  2014-11       Impact factor: 4.283

4.  Influenza Vaccination Can Broadly Activate the HIV Reservoir During Antiretroviral Therapy.

Authors:  Aaron Christensen-Quick; Antoine Chaillon; Christina Yek; Fabio Zanini; Parris Jordan; Caroline Ignacio; Gemma Caballero; Sara Gianella; Davey Smith
Journal:  J Acquir Immune Defic Syndr       Date:  2018-11-01       Impact factor: 3.731

Review 5.  Macrophages and their relevance in Human Immunodeficiency Virus Type I infection.

Authors:  Herwig Koppensteiner; Ruth Brack-Werner; Michael Schindler
Journal:  Retrovirology       Date:  2012-10-04       Impact factor: 4.602

6.  Biphasic decay kinetics suggest progressive slowing in turnover of latently HIV-1 infected cells during antiretroviral therapy.

Authors:  Marek Fischer; Beda Joos; Barbara Niederöst; Philipp Kaiser; Roland Hafner; Viktor von Wyl; Martina Ackermann; Rainer Weber; Huldrych F Günthard
Journal:  Retrovirology       Date:  2008-11-26       Impact factor: 4.602

7.  CD38 Expression in a Subset of Memory T Cells Is Independent of Cell Cycling as a Correlate of HIV Disease Progression.

Authors:  Daniela Würsch; Christopher E Ormsby; Dámaris P Romero-Rodríguez; Gustavo Olvera-García; Joaquín Zúñiga; Wei Jiang; Santiago Pérez-Patrigeon; Enrique Espinosa
Journal:  Dis Markers       Date:  2016-03-14       Impact factor: 3.434

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.